Atorvastatin enhances cellular uptake of oxidized LDL in adipocytes from hypercholesterolemic rabbits

Clinica Chimica Acta

Volumn 339, Issue 1-2, 2004, Pages 189-194

  Zhao, Shui Ping ^a   Zhang, Da Qing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adipocytes; Hypercholesterolemia; Oxidized LDL; PPAR ; Statins

Indexed keywords

ATORVASTATIN; CD36 ANTIGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ADIPOSE TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONCENTRATION RESPONSE; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; LIPID TRANSPORT; MALE; MONOCYTE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE;

ORYCTOLAGUS CUNICULUS;

EID: 0347627261     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2003.10.007     Document Type: Article

References (25)

1. Stears A.J., Byrne C.D. Adipocyte metabolism and the metabolic syndrome. Diabetes Obes. Metab. 3(3):2001;129-142.
2. Toshima S., Hasegawa A., Nagai R. Circulating oxidized low density lipoprotein concentrations a biochemical risk marker for coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 20(10):2000;2243-2247.
3. Kliewer S.A., Lehmann J.M., Willson T.M. Orphan nuclear receptors: shifting endocrinology into reverse. Science. 284(5415):1999;757-760.
4. Evan D.R., Pasha S., Troy A.E.et al. PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol. Cell. 4(4):1999;611-617.
5. Han S., Sidell N. Peroxisome proliferator-activated-receptor gamma (PPARgamma) independent induction of CD36 in THP-1 monocytes by retinoic acid. Immunology. 106(1):2002;9-53.
6. Endemann G., Stanton L.W., Madden K.S.et al. CD36 is a receptor for oxidized low-density lipoprotein. J. Biol. Chem. 268(16):1993;11811-11816.
7. Aitman T.J. CD36, insulin resistance, and coronary heart disease. Lancet. 357(9257):2001;651-652.
8. Takemoto M., Liao J.K. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21(11):2001;1712-1719.
9. Sposito A.C., Chapman M.J. Statin therapy in acute coronary syndromes mechanistic insight into clinical benefit. Arterioscler. Thromb. Vasc. Biol. 22(10):2002;1524-1534.
10. Grip O., Janciauskiene S., Lindgren S. Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes. Inflamm. Res. 51(2):2002;58-62.
11. Bustos C., Hernandez-Presa M.A., Ortego M.et al. HMG-coA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J. Am. Coll. Cardiol. 32(7):1998;2057-2064.
12. Rodbell M. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 239:1963;375-380.
13. Zhang H.H., Kumar S., Barnett A.H., Eggo M.C. Ceiling culture of mature human adipocytes: use in studies of adipocyte functions. J. Endocrinol. 164(2):2000;119-128.
14. Salacinski P.R., McLean C., Sykes J.E., Clement-Jones V., Lowry P. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent, 3,4,6-tetrachloro-3 alpha, 6 alpha-diphenyl glycoluril (Iodogen). J. Anal. Biochem. 117(1):1981;136-146.
15. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G.et al. The nuclear receptor superfamily: the second decade. Cell. 83(6):1995;835-839.
16. de Vries H.E., Buchner B., van Berkel T.J.et al. Specific interaction of oxidized low-density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 19(3):1999;638-645.
17. Chirgwin J.M., Przybyla A.E., MacDonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 28:1979;5294-5299.
18. Tontonoz P., Nagy L., Alvarez J.G.A., Thomazy V.A., Evans R.M. PPAR promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93(2):1998;241-252.
19. Nozaki S., Kashiwagi H., Yamashita S., Nakagawa T.et al. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J. Clin. Invest. 96(4):1995;1859-1865.
20. Kuniyasu A., Hayashi S., Nakayama H. Adipocytes recognize and degrade oxidized low-density lipoprotein through CD36. Biochem. Biophys. Res. Commun. 295(2):2002;319-323.
21. Krause B.R., Hartman A.D. Adipose tissue and cholesterol metabolism. J. Lipid Res. 25:1984;97-110.
22. Schreibman P.H., Dell R.B. Human adipocyte cholesterol. Concentration, localization, synthesis, and turnover. J. Clin. Invest. 55(5):1975;986-993.
23. Fajas L., Schoonjas K., Gelman L.et al. Regulation of peroxisome proliferator-activated receptor g expression by adipocyte differentiation and determination factor 1/sterolregulatory element binding protein: 1. Implications for adipocyte differentiation and metabolism. Mol. Cell. Biol. 19(8):1999;5495-5503.
24. Zelvyte I., Dominaitiene R., Crisby M., Janciauskiene S. Modulation of inflammatory mediators and PPARgamma and NF-kappaB expression by pravastatin in response to lipoproteins in human monocytes in vitro. Pharmacol. Res. 45(2):2002;147-154.
25. Le Lay S., Robichon C., Le Liepvre X. Regulation of ABCA1 expression and cholesterol efflux during adipose differentiation of 3T3-L1 cells. J. Lipid Res. 44(8):2003;1499-1507.